Ledger.Open graph →
SEC Form D · filed October 26, 2021

INNOCAN PHARMA Corp

Offering
$6.6M
Sold
$6.6M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
CALGARY, Alberta, Canada
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (16)

Yoram Drucker · VALLEY STREAM, NYExec · DirectorRalph Bossino · Calgary, Alberta, CanadaDirectorPeter A. Bloch · Calgary, Alberta, CanadaDirectorIris Bincovich · Calgary, Alberta, CanadaExec · DirectorJoshua A. Lintern · Calgary, Alberta, CanadaDirectorEyal Flom · Calgary, Alberta, CanadaDirectorNelson A. Halpen · Calgary, Alberta, CanadaExecRon Mayron · Hod Hasharon, L3Exec · DirectorRalph Bossino · Calgary, Alberta, CanadaDirectorPeter A. Bloch · Calgary, Alberta, CanadaDirectorYoram Drucker · Tel Aviv, L3Exec · DirectorIris Bincovich · Calgary, Alberta, CanadaExec · DirectorJoshua A. Lintern · Calgary, Alberta, CanadaDirectorEyal Flom · Calgary, Alberta, CanadaDirectorNelson A. Halpen · Calgary, Alberta, CanadaExecRon Mayron · Hod Hasharon, L3Exec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗